Effects of spike protein and toxin-like peptides found in COVID-19

Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination

Mixture effects on synaptogenesis. NSCs were differentiated for 7 DIV

Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2

Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization - Computational and Structural Biotechnology Journal

Extracellular vesicles as carriers of mRNA: Opportunities and challenges in diagnosis and treatment

Restoration of Brain Angiotensin-Converting Enzyme 2 Alleviates Neurological Deficits after Severe Traumatic Brain Injury via Mitigation of Pyroptosis and Apoptosis

PDF) Toxin-like peptides in plasma, urine and faecal samples from COVID-19 patients

Effects of spike protein and toxin-like peptides found in COVID-19 patients on human 3D neuronal/glial model undergoing differentiation: Possible implications for SARS-CoV-2 impact on brain development - ScienceDirect

SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies

Toxin-like peptides in

IJMS, Free Full-Text

Reproductive Toxicology, The impact of maternal viral infections on pre- and postnatal development of the conceptus